HIGH-THROUGHPUT CHEMICAL SCREEN OF PATIENT DERIVED GBM TUMOR INITIALIZING CELLS

PI: Greg D. Foltz, M.D.
Director, The Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment
Swedish Medical Center

Close Menu